Abstract
T cell alloreactivity is responsible for much of the morbidity and mortality associated with tissue transplantation and graft versus host disease. Immunoassays for ex vivo monitoring and quantitation of alloreactive T cells are being increasingly utilised to provide valuable information for individualised clinical management of transplant recipients. Here we describe detailed methodologies for both traditional and novel assays utilised for the detection, quantitation, and functional characterisation of alloreactive T cells and highlight the key advantages and disadvantages of each system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Burrows SR, Khanna R, Burrows JM, Moss DJ (1994) An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein–Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med 179(4):1155–1161
Brunner KT, Mauel J, Cerottini JC, Chapuis B (1968) Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14(2):181–196
Lefkovits I (1972) Induction of antibody-forming cell clones in microcultures. Eur J Immunol 2(4):360–366
Lefkovits I, Waldmann H (1984) Limiting dilution analysis of cells of the immune system I. The clonal basis of the immune response. Immunol Today 5:265–268
Waldmann H, Lefkovits I (1984) Limiting dilution analysis of cells of the immune system II: what can be learnt? Immunol Today 5:295–298
Sharrock CE, Kaminski E, Man S (1990) Limiting dilution analysis of human T cells: a useful clinical tool. Immunol Today 11(8):281–286
Hickling JK (1998) Measuring human T-lymphocyte function. Expert Rev Mol Med 1:1–20
Kaminski E, Hows J, Brookes P, Mackinnon S, Hughes T, Avakian O et al (1989) Alloreactive cytotoxic T-cell frequency analysis and HLA matching for bone marrow transplants from HLA matched unrelated donors. Transplant Proc 21(1 Pt 3):2976–2977
Macdonald WA, Chen Z, Gras S, Archbold JK, Tynan FE, Clements CS et al (2009) T cell allorecognition via molecular mimicry. Immunity 31(6):897–908
Bharadwaj M, Thammanichanond D, Aitken CK, Moneer S, Drummer HE, Tracy S et al (2009) TCD8 response in diverse outcomes of recurrent exposure to hepatitis C virus. Immunol Cell Biol 87(6):464–472
Bharadwaj M, Burrows SR, Burrows JM, Moss DJ, Catalina M, Khanna R (2001) Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein–Barr virus infection. Blood 98(8):2588–2589
Kaminski E, Hows J, Man S, Brookes P, Mackinnon S, Hughes T et al (1989) Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 48(4):608–613
Schwarer AP, Jiang YZ, Deacock S, Brookes PA, Barrett AJ, Goldman JM et al (1994) Comparison of helper and cytotoxic antirecipient T cell frequencies in unrelated bone marrow transplantation. Transplantation 58(11):1198–1203
Roelen DL, Stobbe I, Young NT, van Bree SP, Doxiadis II, Oudshoorn M et al (2001) Permissible and immunogenic HLA-A mismatches: cytotoxic T-cell precursor frequencies reflect graft survival data. Hum Immunol 62(7):661–667
Dolezalova L, Vrana M, Dobrovolna M, Loudova M, Cukrova V, Vitek A et al (2002) Cytotoxic T lymphocyte precursor frequency analysis in the selection of HLA matched unrelated donors for hematopoietic stem cell transplantation: the correlation of CTLp frequency with HLA class I genotyping and aGVHD development. Neoplasma 49(1):26–32
Fussell ST, Donnellan M, Cooley MA, Farrell C (1994) Cytotoxic T lymphocyte precursor frequency does not correlate with either the incidence or severity of graft-versus-host disease after matched unrelated donor bone marrow transplantation. Transplantation 57(5):673–676
Eberspacher ML, Otto G, Herfarth C, Kabelitz D (1994) Frequency analysis of donor-reactive cytotoxic T lymphocyte precursors in in allograft recipients. Lack of correlation with clinical outcome. Transplantation 57(12):1746–1752
Wang XN, Taylor PR, Skinner R, Jackson GH, Proctor SJ, Hedley D et al (2000) T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation. TransÂplantation 70(3):488–493
Tan LC, Gudgeon N, Annels NE, Hansasuta P, O’Callaghan CA, Rowland-Jones S et al (1999) A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol 162(3):1827–1835
Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ (1997) Rapid effector function in CD8+ memory T cells. J Exp Med 186(6):859–865
Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD et al (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8(2):177–187
Kuzushima K, Hoshino Y, Fujii K, Yokoyama N, Fujita M, Kiyono T et al (1999) Rapid determination of Epstein–Barr virus-specific CD8(+) T-cell frequencies by flow cytometry. Blood 94(9):3094–3100
Hernandez-Fuentes MP, Warrens AN, Lechler RI (2003) Immunologic monitoring. Immunol Rev 196:247–264
Miyahira Y, Murata K, Rodriguez D, Rodriguez JR, Esteban M, Rodrigues MM et al (1995) Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J Immunol Methods 181(1):45–54
Czerkinsky C, Andersson G, Ekre HP, Nilsson LA, Klareskog L, Ouchterlony O (1988) Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods 110(1):29–36
Elliott SL, Suhrbier A, Miles JJ, Lawrence G, Pye SJ, Le TT et al (2008) Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis. J Virol 82(3):1448–1457
Scheibenbogen C, Romero P, Rivoltini L, Herr W, Schmittel A, Cerottini JC et al (2000) Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial. J Immunol Methods 244(1–2):81–89
Pelfrey CM, Rudick RA, Cotleur AC, Lee JC, Tary-Lehmann M, Lehmann PV (2000) Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production. J Immunol 165(3):1641–1651
Bestard O, Nickel P, Cruzado JM, Schoenemann C, Boenisch O, Sefrin A et al (2008) Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. J Am Soc Nephrol 19(7):1419–1429
Sherritt MA, Bharadwaj M, Burrows JM, Morrison LE, Elliott SL, Davis JE et al (2003) Reconstitution of the latent T-lymphocyte response to Epstein–Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy. Transplantation 75(9):1556–1560
Gazagne A, Claret E, Wijdenes J, Yssel H, Bousquet F, Levy E et al (2003) A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines. J Immunol Methods 283(1–2):91–98
Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI et al (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274(5284):94–96
McMichael AJ, O’Callaghan CA (1998) A new look at T cells. J Exp Med 187(9):1367–1371
Ogg GS, McMichael AJ (1998) HLA-peptide tetrameric complexes. Curr Opin Immunol 10(4):393–396
Miles JJ, Thammanichanond D, Moneer S, Nivarthi UK, Kjer-Nielsen L, Tracy SL et al (2011) Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection. J Immunol 186(2):901–912
James EA, LaFond R, Durinovic-Bello I, Kwok W (2009) Visualizing antigen specific CD4+ T cells using MHC class II tetramers. J Vis Exp (25) pii:1167
Landais E, Romagnoli PA, Corper AL, Shires J, Altman JD, Wilson IA et al (2009) New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation. J Immunol 183(12):7949–7957
Vollers SS, Stern LJ (2008) Class II major histocompatibility complex tetramer staining: progress, problems, and prospects. Immunology 123(3):305–313
Raddassi K, Kent SC, Yang J, Bourcier K, Bradshaw EM, Seyfert-Margolis V et al (2011) Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis. J Immunol 187(2):1039–1046
Laughlin E, Burke G, Pugliese A, Falk B, Nepom G (2008) Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation. Clin Immunol 128(1):23–30
Bonvalet M, Wambre E, Moussu H, Horiot S, Kwok WW, Louise A et al (2011) Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4(+) T cells. Clin Exp Allergy 41(6):821–829
Ayyoub M, Dojcinovic D, Pignon P, Raimbaud I, Schmidt J, Luescher I et al (2010) Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramers. Proc Natl Acad Sci USA 107(16):7437–7442
Cusick MF, Yang M, Gill JC, Eckels DD (2011) Naturally occurring CD4+ T-cell epitope variants act as altered peptide ligands leading to impaired helper T-cell responses in hepatitis C virus infection. Hum Immunol 72(5):379–385
Sun Y, Iglesias E, Samri A, Kamkamidze G, Decoville T, Carcelain G et al (2003) A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J Immunol Methods 272(1–2):23–34
McMichael AJ, Ogg G, Wilson J, Callan M, Hambleton S, Appay V et al (2000) Memory CD8+ T cells in HIV infection. Philos Trans R Soc Lond B Biol Sci 2355(1395):363–367
Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S et al (1998) Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279(5359):2103–2106
Callan MF, Tan L, Annels N, Ogg GS, Wilson JD, O’Callaghan CA et al (1998) Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein–Barr virus In vivo. J Exp Med 187(9):1395–1402
Mifsud NA, Nguyen TH, Tait BD, Kotsimbos TC (2010) Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients. Transplantation 90(12):1439–1449
Nguyen TH, Sullivan LC, Kotsimbos TC, Schwarer AP, Mifsud NA (2010) Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells. Immunol Cell Biol 88(6):676–684
Pala P, Hussell T, Openshaw PJ (2000) Flow cytometric measurement of intracellular cytokines. J Immunol Methods 243(1–2):107–124
Prussin C, Metcalfe DD (1995) Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 188(1):117–128
Goulder PJ, Tang Y, Brander C, Betts MR, Altfeld M, Annamalai K et al (2000) Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med 192(12):1819–1832
Asemissen AM, Nagorsen D, Keilholz U, Letsch A, Schmittel A, Thiel E et al (2001) Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells. J Immunol Methods 251(1–2):101–108
Whiteside TL, Zhao Y, Tsukishiro T, Elder EM, Gooding W, Baar J (2003) Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma. Clin Cancer Res 9(2):641–649
Koehne G, Smith KM, Ferguson TL, Williams RY, Heller G, Pamer EG et al (2002) Quantitation, selection, and functional characterization of Epstein–Barr virus-specific and alloreactive T cells detected by intracellular interferon-gamma production and growth of cytotoxic precursors. Blood 99(5):1730–1740
Waldrop SL, Pitcher CJ, Peterson DM, Maino VC, Picker LJ (1997) Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 99(7):1739–1750
Mifsud NA, Purcell AW, Chen W, Holdsworth R, Tait BD, McCluskey J (2008) ImmuÂnodominance hierarchies and gender bias in direct T(CD8)-cell alloreactivity. Am J Transplant 8(1):121–132
Allen KJ, Mifsud NA, Williamson R, Bertolino P, Hardikar W (2008) Cell-mediated rejection results in allograft loss after liver cell transplantation. Liver Transpl 14(5):688–694
Elkington R, Walker S, Crough T, Menzies M, Tellam J, Bharadwaj M et al (2003) Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J Virol 77(9):5226–5240
Taswell C (1981) Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126(4):1614–1619
Strijbosch LW, Buurman WA, Does RJ, Zinken PH, Groenewegen G (1987) Limiting dilution assays. Experimental design and statistical analysis. J Immunol Methods 97(1):133–140
Acknowledgements
The authors would like to thank Ms Patricia Therese Illing, The University of Melbourne, Australia, for her help in proofreading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Bharadwaj, M., Mifsud, N.A., McCluskey, J. (2012). Detection and Characterisation of Alloreactive T Cells. In: Christiansen, F., Tait, B. (eds) Immunogenetics. Methods in Molecular Biology, vol 882. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-842-9_18
Download citation
DOI: https://doi.org/10.1007/978-1-61779-842-9_18
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-841-2
Online ISBN: 978-1-61779-842-9
eBook Packages: Springer Protocols